Drug intelligence / Profile preview

Osteohalt

Development stage
Unknown
Lead developer
Primus Remedies
Modality
Small Molecules
Administration
Oral
01

Overview

Osteohalt (including Osteohalt Plus) is a line of oral joint health supplements developed by Primus Remedies, primarily indicated for the management of osteoarthritis, rheumatoid arthritis, and general joint discomfort. The standard Osteohalt formulation is a fixed-dose combination containing glucosamine, diacerein, methylsulfonylmethane (MSM), hyaluronic acid, and Boswellia extract. The Osteohalt Plus formulation contains glucosamine, chondroitin sulfate, rose hip extract, hyaluronic acid, ascorbic acid (vitamin C), collagen, and curcumin (Curcuma longa extract). Together, these ingredients work synergistically to support cartilage repair, reduce joint inflammation, slow cartilage degradation, and improve joint lubrication and mobility. Diacerein acts as an interleukin-1 beta (IL-1β) inhibitor to slow joint degeneration, while Boswellia extract and curcumin inhibit inflammatory pathways such as 5-lipoxygenase (5-LOX) and cyclooxygenase-2 (COX-2). Glucosamine and chondroitin serve as essential building blocks for cartilage synthesis, and hyaluronic acid provides joint lubrication.

Brand names
OsteohaltOsteohalt Plus
02

Targets

ALOX5 (Arachidonate 5-lipoxygenase)CD44 (CD44 antigen)IL1B (Interleukin-1 beta)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Osteohalt.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteohalt.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call